Baricitinib therapy in COVID-19: A pilot study on safety and clinical impactFabrizio Cantini, Delia Goletti|Journal of Infection|2020Cited by 445
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre studyFabrizio Cantini, Delia Goletti|Journal of Infection|2020Cited by 179